Polyamine and Glutamate Driven Interactions in the Glioblastoma-Brain Microenvironment
胶质母细胞瘤-脑微环境中多胺和谷氨酸驱动的相互作用
基本信息
- 批准号:10450174
- 负责人:
- 金额:$ 34.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-07 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AdoptedApoptosisArchitectureBloodBrainBrain GlioblastomaBrain InjuriesBrain NeoplasmsCRISPR/Cas technologyCell DeathCellsCessation of lifeClinicalClustered Regularly Interspaced Short Palindromic RepeatsCognitionCognitiveCognitive deficitsConformal RadiotherapyCranial IrradiationDNA Repair GeneDendritesDiseaseDose-LimitingEffectivenessElectrophysiology (science)ElectroporationEmbryoEnzymesEventExcitatory Amino Acid AntagonistsExposure toFlow CytometryFrequenciesGene ExpressionGenetic ModelsGlioblastomaGliomaGlutamate Metabolism PathwayGlutamate ReceptorGlutamatesGlutamineHippocampus (Brain)HourImmunocompetentImmunotherapyImpaired cognitionIonizing radiationLeadLesionLinkMediatingMediator of activation proteinModalityModelingMorbidity - disease rateMusN-Methyl-D-Aspartate ReceptorsNatureNervous System TraumaNeuraxisNeuronsNeurotransmittersNormal tissue morphologyOrganPathway interactionsPatient-Focused OutcomesPatientsPharmacologyPhosphorylationPlayPolyaminesProtonsRadiationRadiation InteractionRadiation ToleranceRadiation exposureRadiation induced damageRadiation therapyRadiation-Sensitizing AgentsRadiosensitizationReceptor SignalingResistanceRoentgen RaysRoleSignal PathwaySignal TransductionSliceSpecificityStructureSystemTherapeuticTimeToxic effectTumor Suppressor Genesadverse outcomeautocrinebasecell typeexcitotoxicityextracellulargene therapygenome editingglutamatergic signalingifenprodilimprovedimproved outcomein uteroinhibitorinnovationinsightirradiationneoplastic cellneuroinflammationneuron lossneurotoxicityneutralizing monoclonal antibodiesnovelparticle therapypreclinical studyprotective effectradiation resistanceradioresistantstandard of caretherapy resistanttumortumor growth
项目摘要
Project Summary
Radiotherapy is a standard modality for brain lesions, and has led improvements in patient outcome through
the addition of high precision stereotactic delivery and more recently particle therapy. While patients are
benefiting from increasing survival times, cognitive complications develop with increased frequency and are
thus challenging treatment paradigms. Biologically, the mechanisms of neurotoxicity from ionizing radiation
are unclear. Recent studies have highlighted exquisite sensitivity to an organ that has been traditionally
thought to be radioresistant due to its non-proliferative nature. Dendrite remodeling, neuroinflammation, and
excitotoxicity are all elevated following exposure to ionizing radiation, and are thought to contribute to
decreased cognition. In the current application, we propose that excessive glutamate signaling is a key driver
of cognitive damage from radiation. In addition, our group has been investigating the role of the polyamine
pathway in radiation resistance of tumor cells. Both glutamate and polyamines are found to be elevated in
brain tumors, an induced secretion is evident after exposure to radiation. In mechanistic studies, we implicate
the NMDAR NR2B subunit as a specific target of glutamate and polyamines that leads to neurotoxicity. We
hypothesize that blocking glutamate-receptor signaling with a specific glutamate receptor antagonist will
reduce CNS damage due to radiation, and sensitize tumor cells to radiation induced death, and therefore
improve patient outcomes.
项目摘要
放疗是脑损伤的标准方式,并通过
添加高精度立体定向递送和最近的粒子疗法。而患者是
受益于增加生存时间,认知并发症随频率的增加而发展,并且
因此挑战治疗范例。从生物学上讲,神经毒性从电离辐射中的机制
不清楚。最近的研究强调了对传统上的器官的精致敏感性
由于其非增殖性质而被认为是放射抗性的。树突重塑,神经炎症和
暴露于电离辐射后,兴奋性毒性均升高,被认为有助于
认知下降。在当前应用中,我们建议过多的谷氨酸信号传导是关键驱动器
辐射的认知损害。此外,我们的小组一直在研究多胺的作用
肿瘤细胞辐射阻力的途径。发现谷氨酸和多胺均升高
暴露于辐射后,脑肿瘤是一种诱发的分泌。在机械研究中,我们暗示
NMDAR NR2B亚基作为谷氨酸和多胺的特定靶标,导致神经毒性。我们
假设用特定的谷氨酸受体拮抗剂阻断谷氨酸受体信号传导将
减少因辐射引起的中枢神经系统损害,并使肿瘤细胞对辐射诱导的死亡敏感,因此
改善患者的预后。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scott Michael Welford其他文献
Scott Michael Welford的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scott Michael Welford', 18)}}的其他基金
Adipokine Signaling as a Therapeutically Targetable Driver of Tumor Metabolism
脂肪因子信号传导作为肿瘤代谢的治疗靶向驱动因素
- 批准号:
10366023 - 财政年份:2021
- 资助金额:
$ 34.07万 - 项目类别:
Adipokine Signaling as a Therapeutically Targetable Driver of Tumor Metabolism
脂肪因子信号传导作为肿瘤代谢的治疗靶向驱动因素
- 批准号:
10580769 - 财政年份:2021
- 资助金额:
$ 34.07万 - 项目类别:
Polyamine and Glutamate Driven Interactions in the Glioblastoma-Brain Microenvironment
胶质母细胞瘤-脑微环境中多胺和谷氨酸驱动的相互作用
- 批准号:
10317530 - 财政年份:2015
- 资助金额:
$ 34.07万 - 项目类别:
Polyamine Catabolism and Therapeutic Resistance in Glioblastoma Multiforme
多形性胶质母细胞瘤的多胺分解代谢和治疗耐药
- 批准号:
9122361 - 财政年份:2015
- 资助金额:
$ 34.07万 - 项目类别:
A novel soluble receptor-based therapy for Kidney Cancer
一种基于可溶性受体的新型肾癌疗法
- 批准号:
8751723 - 财政年份:2014
- 资助金额:
$ 34.07万 - 项目类别:
相似国自然基金
基于巨噬细胞表型转变探讨BTSA1诱导衰老肌成纤维细胞凋亡及促肺纤维化消退的机制
- 批准号:82370077
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
STAB1调控Fas/FasL介导牦牛胎盘滋养层细胞凋亡及胎盘炎症性流产的作用与机制研究
- 批准号:32360836
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
ATAD3A琥珀酰化调控mtDNA损伤-泛凋亡反应轴在心梗后心衰中的作用研究
- 批准号:82300434
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
胸腺肽α-1介导凋亡小体RNA改善DC功能增强TNBC化疗后抗肿瘤免疫应答的机制研究
- 批准号:82303959
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
LSD1通过使组蛋白H3K4位点去甲基化促进自噬参与肾小管上皮细胞凋亡和肾脏纤维化的机制研究
- 批准号:82300769
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 34.07万 - 项目类别:
Interdependency of fibroadipogenic progenitors and extracellular matrix that drive skeletal muscle fibrosis
驱动骨骼肌纤维化的纤维脂肪祖细胞和细胞外基质的相互依赖性
- 批准号:
10454078 - 财政年份:2022
- 资助金额:
$ 34.07万 - 项目类别:
Interdependency of fibroadipogenic progenitors and extracellular matrix that drive skeletal muscle fibrosis
驱动骨骼肌纤维化的纤维脂肪祖细胞和细胞外基质的相互依赖性
- 批准号:
10602460 - 财政年份:2022
- 资助金额:
$ 34.07万 - 项目类别:
Single Molecule Biophysics of Intrinsically Disordered Proteins in Disease
疾病中内在无序蛋白质的单分子生物物理学
- 批准号:
10818667 - 财政年份:2021
- 资助金额:
$ 34.07万 - 项目类别:
Single Molecule Biophysics of Intrinsically Disordered Proteins in Disease
疾病中内在无序蛋白质的单分子生物物理学
- 批准号:
10305403 - 财政年份:2021
- 资助金额:
$ 34.07万 - 项目类别: